Clinical outcome of definitive radiation therapy for superficial esophageal cancer
Yutaro Koide(Nagoya University Hospital), Shinji Naganawa(Nagoya University), Natsuo Tomita(Aichi Cancer Center), Masahiro Tajika(Aichi Cancer Center), Takeshi Kodaira(Aichi Cancer Center), Kei Muro(Aichi Cancer Center), Yoshiyuki Itoh(Nagoya University), Makoto Itoh(Aichi Cancer Center), Hiroyuki Tachibana(Aichi Cancer Center), Tetsuya Abe(Aichi Cancer Center), Yasumasa Niwa(Aichi Cancer Center), Chiyoko Makita(Aichi Cancer Center)
Cited by 13
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
|The Lancet|2018|1.3k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2011|713